Kazia Therapeutics Files Form 6-K
Ticker: KZIA · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1075880
| Field | Detail |
|---|---|
| Company | Kazia Therapeutics LTD (KZIA) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-issuer, regulatory-filing
Related Tickers: KZA
TL;DR
Kazia Therapeutics (KZA) filed a 6-K on 6/11/25. Standard foreign issuer report.
AI Summary
Kazia Therapeutics Limited, formerly Novogen Ltd, filed a Form 6-K on June 11, 2025. The company, headquartered in Sydney, NSW, is a pharmaceutical preparations company. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates Kazia Therapeutics is providing an update as a foreign private issuer, which could contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Kazia Therapeutics Limited (company) — Registrant
- Novogen Ltd (company) — Former company name
- June 11, 2025 (date) — Filing date
- Sydney NSW (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the issuer makes public in its home country, files with a stock exchange, or distributes to its security holders.
When was Kazia Therapeutics Limited previously known as?
Kazia Therapeutics Limited was formerly known as Novogen Ltd, with a date of name change on December 28, 1998.
Where is Kazia Therapeutics Limited's principal executive office located?
The principal executive office of Kazia Therapeutics Limited is located at Three International Towers Level 24, 300 Barangaroo Avenue, Sydney NSW 2000.
What is Kazia Therapeutics Limited's Standard Industrial Classification (SIC) code?
Kazia Therapeutics Limited's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Kazia Therapeutics Limited?
The SEC file number for Kazia Therapeutics Limited is 000-29962.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding KAZIA THERAPEUTICS LTD (KZIA).